Massachusetts-based Black Harbor Group is positioned to purchase Fine Fettle, a licensed cannabis cultivator and manufacturer located on Martha’s Vineyard in West Tisbury, Massachusetts.

The Select Board of West Tisbury unanimously approved the change of ownership for Fine Fettle, which earlier this year announced it would permanently close “no later than September,” according to the Vineyard Gazette.

ADVERTISEMENT

The Select Board of West Tisbury agreed to the transfer of ownership with the stipulation that Fine Fettle address lighting concerns within six months, the Gazette reported.

Black Harbor Group, which was represented by an attorney at the Select Board meeting, was registered as a limited liability company in July, according to public records.

Fine Fettle’s closure earlier this year prompted a lawsuit that led

Read full article on Marijuana Business Daily

Applicants for adult-use marijuana social equity business licenses in Missouri are crying foul after it was revealed that nearly half the licenses awarded in the Kansas City area went to companies registered out of state.

According to The Kansas City Star, “secretive” limited liability companies registered in Wyoming won microbusiness permits over local, Black-owned operators.

ADVERTISEMENT

Wyoming state law shields ownership information from being publicly disclosed.

Not Missouri’s first social equity controversy

This is only the latest round of controversy for adult-use social equity licensing in Missouri, where voters legalized recreational cannabis in November 2022.

Adult-use sales launched the following year at existing medical marijuana dispensaries.

This past March, Missouri regulators revoked nine of 48 social equity permits awarded in an initial round after

Read full article on Marijuana Business Daily

Missouri cannabis regulators recalled more than 23,000 marijuana products from several brands on Tuesday, saying they were not properly tested by Fulton, Missouri-based lab ClearWater Science.

The Missouri Division of Cannabis Regulation (DCR) said it recalled the products because they were not “compliantly” tested, so the agency could not verify whether they meet state health and safety requirements.

ADVERTISEMENT

The DCR said it hasn’t received any reports of adverse effects; people who believe they might be having an adverse reaction should seek medical attention.

Patients and consumers should stop using the recalled products and either dispose of them or return them to the dispensary where they were purchased.

About a month ago, the DCR issued a series of recalls for more than 132,000

Read full article on Marijuana Business Daily